Andrew Abreo participated in an advisory board and received payment from Horizon Therapeutics.
Sara Anvari is the recipient of clinical research funding from NIH/NIAID and DBV Technologies, and has participated in an advisory board for the International FPIES association.
Marcella Aquino has received grant support from American College of Allergy, Asthma, and Immunology. She has received honoraria from the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma, and Immunology for presentations. She has received travel support to attending meetings from the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma, and Immunology. She holds a leadership role for the American College of Allergy, Asthma and Immunology and the American Academy of Allergy, Asthma, and Immunology.
Theresa Bingemann has received consulting fees from Aimmune. She has received honoraria for lectures from Sanofi. She holds leadership roles for the American College of Allergy, Asthma and Immunology, American Board of Allergy and Immunology, and American Academy of Pediatrics.
John Bird has received payments to his institution from Aimmune Therapeutics, Astellas, DBV Technologies, Food Allergy Research and Education (FARE), Genentech, Novartis, Regeneron, and Siolta. He has received personal consulting fees from AllerGenis, Allergy Therapeutics, Before Brands, DBV Technologies, Food Allergy Research and Education (FARE), Genentech, Hanimmunte Therapeutics, HAL Allergy, Novartis, and Nutricia. He has received personal fees for presentations from DBV Technologies, and served as an unpaid independent study monitor for Vedanta.
Terri Brown Whitehorn served as investigator on research studies for DBV Technologies and Regeneron, and received consulting fees from DBV Technologies.
Bradley Chipps is an advisor for, is on the speakers bureau, and has received consultancy fees from Astra Zeneca.
Timothy Chow has received grant support from the American College of Allergy, Asthma and Immunology.
Carla Davis has received grants from the National Institute of Allergy and Infectious Disease, DBV Technologies, Food Allergy Research and Education, Allergenis, Regeneron Pharmaceuticals, Pfizer, and The Scurlock Foundation. She has received payments from the Physician Education Resource. She has participated in advisory boards for Aimmune Therapeutics and DBV Technologies. She has held a leadership position in the Family Faith Healthcare Clinic. She holds stock options in Moonlight Therapeutics.
Karla L. Davis holds stock options in Pfizer, Abbott, Kenvue, Johnson and Johnson, and Abbvie.
Lisa Forbes Satter has received grant support from NIH. She has participated in advisory boards and received payment from Grifols, Horizon, Sobi, Pharming and Takeda. She has been a speaker for UCLA boot camp, Eastern Allergy Society and American College of Allergy, Asthma and Immunology and received honoraria. She has received travel support from Grifols, Horizon, Sobi, Clinical Immunology Society. She received registration as speaker for the American Academy of Allergy, Asthma, and Immunology. She holds a leadership role in Clinical Immunology Society and the American Academy of Allergy, Asthma, and Immunology.
Ruchi Gupta has received grants from Genentech, Melchiorre Family Foundation, Novartis, Sunshine Charitable Foundation, and the Walder Foundation. She has received consulting fees from Aimmune, Allergenis, Food Allergy Research & Education (FARE), Genentech, and Novartis. She has ownership interest in Yobee Care, Inc.
Vivian Hernandez-Trujillo has received grant support from the Immune Deficiency Foundation. She has been a consultant for and received payment from Kaleo, Pharming, National Peanut Board, and the Allergy and Asthma Network. She has participated in webinars and podcasts and received payment from the American College of Allergy, Asthma, and Immunology. She has been on speakers bureau and received payment from Takeda and CSL. She has participated in advisory boards and received payment from Takeda, Bayer, Aimmune, Enzyvant, Pfizer, Regeneron, Sanofi/Genzyme, US World Meds, ARS, Bryn, kaleo and Genentech. She has received honoraria for participation in a panel from Amgen. She has received royalties as an author for UpToDate. She has received travel support as part of committee leadership through AAAAI and AAP Section of Allergy and Immunology- Executive Committee. She has been an expert witness on cases regarding dog allergy and food allergy.
Angela Hogan served on a speaker’s bureau for GSK.
Todd Mahr has received consulting fees from Aerocrine, DBV Technologies, Novartis, and Perrigo; and speakers’ bureau payments from Astra Zeneca, Genentech, GSK, and Sanofi/Regeneron.
Christopher Parrish has received grant support from Regeneron, DBV, NIH/NIAID. He is a consultant for Magellan Rx and has received consulting fees. He is a speaker for Sanofi and has received honoraria. He has received travel support from DBV. He has been part of advisory boards and has received payment from Sanofi and Takeda.
Michael Pistiner has received grants from the Egg Nutrition Center and National Peanut Board. He has received consulting fees from Aimmune and Novartis.
Melinda Rathkopf was on the speaker’s bureau and received payment from Teva.
Markus Shaker receives a stipend for work as Associate Editor of Annals of Allergy, Asthma, and Immunology, as well as honoraria for CME talks and lectures for AAAAI, ACAAI, Eastern Food Allergy and Comorbidity Conference, Regional and State Local Allergy Societies.
Scott Sicherer serves as deputy editor of Journal of Allergy and Clinical Immunology: In Practice and received honoraria.
Elinor Simons has received grants from Children's Hospital Research Institute of Manitoba and Canadian Institutes of Health Research.
David Stukus is a consultant for ARS and Novartis and has received consulting fees. He is part of leadership for ACAAI and AAP. He is Associate Editor for the Annals of Allergy, Asthma and Immunology and Social media editor for AAAAI and receives payment.
Pooja Varshney has received payments to her institution from Aimmune, DBV Technologies, and Siolta. She has received a grant for provision of grocery cards to patients from Dell Children's Medical Center Pediatrics Advocacy Grant. She received travel expense payment from DBV Technologies. She participated in an advisory board for Food Allergy Research & Education (FARE). She is a medical director and principal investigator for FARE Clinical Research Center of Distinction.
Luke Wall reports payments to his institution from Takeda and Chiesi.
Julie Wang received grant support from NIH, Aimmune, DBV Technologies, Siolta, and Regeneron. She has received royalties from UptoDate. She has received travel support from AAAAI and AAP as part of committee participation. She is a member of ALK Abello Data Safety Monitoring Board. She has participated in an advisory bord and received payment from Jubilant Hollister Stier.
Kelli Williams has received grant support from Regeneron, Glaxo Smith Kline, and ADMA biologicals. She has been a consultant for and received consultant fees from Pharming. She has been a speaker for and received payment from the Pennsylvania Allergy and Immunology Society and Swineford Allergy Annual Meeting. She has participated in advisory boards and received payment from Horizon, Pfizer, Genentech, Enzyvant, Pharming and Kenota Health. She holds leadership positions with AAAAI, Clinical Immunology Society, and Allergy, Asthma, and Immunology Society of South Carolina.
Stuart Abramson, Timothy Andrews, Jeffrey Chambliss, Alan Goldsobel, Akilah Jefferson, John Kelso, Susan Laubach, Harvey Leo, Mitchell Lester, Lindsey Moore, Jordan Orange, Girish Vitalpur, Elizabeth Wisner, and Joyce Yu report nothing to disclose.
Comments